Finance

Lists
9989:HKG
Shenzhen Hepalink Pharmaceutical Group Ord Shs H
3,96 HKD
+0,89%
(+0,035) 1D
16 ოქტ, 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 9989...
Open
3,98 HKD
High
4,00 HKD
Low
3,94 HKD
Mkt. cap
14,72 მლრდ.
Avg. vol.
589,50 ათ.
Volume
1,04 მლნ.
Dividend
4,19%
Quarterly dividend
0,04 HKD
Ex-dividend date
18 ივნ. 2026
P/E ratio
24,42
52-wk high
5,77 HKD
52-wk low
3,74 HKD
EPS
0,16 HKD
Shares outstanding
220,09 მლნ.
No. of employees
2 ათ.
Open
3,98 HKD
High
4,00 HKD
Low
3,94 HKD
Mkt. cap
14,72 მლრდ.
Avg. vol.
589,50 ათ.
Volume
1,04 მლნ.
Dividend
4,19%
Quarterly dividend
0,04 HKD
Ex-dividend date
18 ივნ. 2026
P/E ratio
24,42
52-wk high
5,77 HKD
52-wk low
3,74 HKD
EPS
0,16 HKD
Shares outstanding
220,09 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
About Shenzhen Hepalink Pharmaceutical Group Ord Shs H
CEO-
Employees2,1 ათ.
Founded21 აპრ. 1998
Headquarters-
SectorPharmaceutical industry
Websitehepalink.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,38 მლრდ.
1,28 მლრდ.
1,33 მლრდ.
1,25 მლრდ.
Cost of goods sold
884,21 მლნ.
900,40 მლნ.
876,31 მლნ.
826,48 მლნ.
Cost of revenue
884,21 მლნ.
900,40 მლნ.
876,31 მლნ.
826,48 მლნ.
Research and development expenses
73,11 მლნ.
50,33 მლნ.
36,44 მლნ.
45,89 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
216,50 მლნ.
252,73 მლნ.
209,31 მლნ.
238,09 მლნ.
Operating expense
291,36 მლნ.
336,08 მლნ.
263,62 მლნ.
301,09 მლნ.
Total operating expenses
1,18 მლრდ.
1,24 მლრდ.
1,14 მლრდ.
1,13 მლრდ.
Operating income
201,54 მლნ.
48,03 მლნ.
190,92 მლნ.
121,10 მლნ.
Other non operating income
182,67 მლნ.
-254,18 მლნ.
-122,99 მლნ.
121,83 მლნ.
EBT including unusual items
157,96 მლნ.
-239,36 მლნ.
207,68 მლნ.
72,85 მლნ.
EBT excluding unusual items
188,04 მლნ.
-97,72 მლნ.
93,38 მლნ.
76,27 მლნ.
Income tax expense
26,52 მლნ.
-29,37 მლნ.
20,31 მლნ.
-14,68 მლნ.
Effective tax rate
16,79%
12,27%
9,78%
-20,15%
Other operating expenses
6,60 მლნ.
16,33 მლნ.
8,11 მლნ.
7,92 მლნ.
Net income
131,73 მლნ.
-204,09 მლნ.
187,57 მლნ.
87,71 მლნ.
Net profit margin
9,57%
-15,89%
14,09%
7,02%
Earnings per share
-
-
-
-
Interest and investment income
33,52 მლნ.
-
38,50 მლნ.
1,33 მლნ.
Interest expense
-15,15 მლნ.
-32,17 მლნ.
-13,05 მლნ.
-12,63 მლნ.
Net interest expenses
18,37 მლნ.
-32,17 მლნ.
25,45 მლნ.
-11,30 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
271,82 მლნ.
128,19 მლნ.
271,08 მლნ.
201,09 მლნ.
Gain or loss from assets sale
1,29 მლნ.
-1,84 მლნ.
-
26,67 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები